VC
RGNX icon

Vivo Capital’s Regenxbio RGNX Stock Holding History

Vivo Capital’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-82,403
Closed -$5.91M – 46
2018
Q2 		$5.91M Sell
82,403
-82,000
-50% -$3.92M 0.76% 28
2018
Q1 		$4.91M Hold
164,403
– – 0.7% 24
2017
Q4 		$5.47M Hold
164,403
– – 1.17% 20
2017
Q3 		$5.42M Hold
164,403
– – 1.09% 19
2017
Q2 		$3.25M Hold
164,403
– – 0.82% 19
2017
Q1 		$3.17M Sell
164,403
-338,460
-67% -$6.53M 0.93% 18
2016
Q4 		$9.33M Sell
502,863
-487,586
-49% -$9.32M 3.07% 10
2016
Q3 		$13.9M Hold
990,449
– – 4.32% 8
2016
Q2 		$7.92M Hold
990,449
– – 2.16% 12
2016
Q1 		$10.7M Buy
+990,449
New +$12.7M 2.68% 11

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vivo Capital's RGNX Position: Q3 2018 in Review

Vivo Capital sold out of Regenxbio (RGNX) in Q3 2018, closing a stake of 82,403 shares — an estimated $5.91M sold.

Vivo Capital first reported a position in RGNX in Q1 2016 and held it in 10 quarters. The position peaked at $13.9M in Q3 2016. 203 funds tracked by Wall St. Rank hold RGNX as of Q3 2018.

  • Vivo Capital reported no remaining Regenxbio position as of Q3 2018 after selling out during the quarter.
  • Vivo Capital sold 82,403 Regenxbio shares in Q3 2018, an estimated $5.91M.
  • Vivo Capital first reported a position in Regenxbio in Q1 2016 and held it in 10 quarters.
  • Vivo Capital's Regenxbio position peaked at $13.9M in Q3 2016.
  • 203 funds tracked by Wall St. Rank held Regenxbio as of Q3 2018.

Based on Vivo Capital's 13F filing for Q3 2018, filed 13 Nov 2018.